This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Buy in September
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Office Properties Income Trust (OPI), KB Financial Group (KB), PagSeguro Digital Ltd. (PAGS) and EnerSys (ENS) are some such stocks.
Zacks.com featured highlights Select Medical, EnerSys, O-I Glass and PagSeguro
by Zacks Equity Research
Select Medical, EnerSys, O-I Glass and PagSeguro have been highlighted in this Screen of The Week article.
Encompass Health (EHC) Opens JV Hospital With Piedmont in Georgia
by Zacks Equity Research
The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia.
Pick These 4 Low P/CF Stocks for a Balanced Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical Holdings (SEM), EnerSys (ENS), O-I Glass (OI) and PagSeguro Digital (PAGS) boast low P/CF ratios.
Brookdale's (BKD) August 2023 Occupancy & Move-in Volumes Rise
by Zacks Equity Research
Brookdale (BKD) has witnessed 22 straight months of year-over-year increases in the weighted average occupancy level.
Molina Healthcare (MOH) Closes $150M My Choice Wisconsin Buyout
by Zacks Equity Research
Molina Healthcare (MOH) completes the My Choice Wisconsin acquisition ahead of the updated scheduled time.
Here's Why Investors are Retaining Elevance (ELV) Stock Now
by Zacks Equity Research
Elevance's (ELV) focus on expanding the capabilities of the Carelon platform is likely to position the company for long-term growth.
Here's Why You Should Retain UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growth in membership, expanding government business, strategic acquisitions and improving operating margin poise UnitedHealth Group (UNH) well for growth.
Cigna's (CI) Unit Brings New Plan for Globally Mobile Seniors
by Zacks Equity Research
The new product from Cigna's (CI) Cigna Healthcare unit is likely to face significant demand in the global market.
3 MedTech Stocks to Bet on Potential Pause of Rate Hike by Fed
by Indrajit Bandyopadhyay
Interest rates impact the healthcare industry and medical device companies in various ways. Here we discuss three companies HCA, ALC and SEM that are likely to gain potential pause in rate hikes.
Select Medical (SEM) Up 18% Year to Date: More Room to Run?
by Zacks Equity Research
Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with strong cash-generating abilities.
HCA Healthcare (HCA) & Google Cloud Unite to Improve Efficiency
by Zacks Equity Research
HCA Healthcare (HCA) partners with Google Cloud to improve and automate workflows.
Why Investors Are Snapping Up Tenet Healthcare (THC) Stock Now
by Zacks Equity Research
Tenet Healthcare (THC) patient volumes are likely to remain high as seniors resume elective procedures, which were delayed due to pandemic-related constraints.
Cigna (CI) Unit to Offer ACA Plans in 350 Counties in 2024
by Zacks Equity Research
Cigna (CI) plans to expand coverage in 15 counties in North Carolina and reach an additional 200,000 ACA Marketplace clients.
5 Stocks With Attractive Price-to-Book Ratio Worth a Look
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), General Motors Company (GM), KB Financial Group (KB), StoneCo Ltd. (STNE) and Corebridge Financial (CRBG) are some such stocks.
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is UnitedHealth (UNH) a Good Dividend Stock Choice for You?
by Zacks Equity Research
UnitedHealth's (UNH) strong balance sheet and cash-generating ability support its endeavors to return shareholders' funds.
Why Prudent Investors Are Snapping Up Ensign (ENSG) Stock Now
by Zacks Equity Research
Ensign (ENSG) expects to witness strong acquisition opportunities in the fall of this year.
Here's Why Encompass Health (EHC) Stock is a Strong Buy Now
by Zacks Equity Research
Encompass Health's (EHC) focus on boosting the number of licensed beds and hospitals will likely enhance market density and build scale.
Brookdale Senior (BKD) Shares Jump 18.7% Since Q2 Earnings Beat
by Zacks Equity Research
Brookdale Senior (BKD) expects adjusted EBITDA to be within the $73-$78 million range in the third quarter.
The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit
by Zacks Equity Research
The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.
Select Medical (SEM) Q2 Earnings Meet, Revenues Rise Y/Y
by Zacks Equity Research
Select Medical's (SEM) Q2 results reflect solid segmental revenues, attributable to higher patient days and outpatient visits. Management projects adjusted EPS of $1.86-$2.03 for 2023.
Will US Business Strength Aid Acadia's (ACHC) Q2 Earnings?
by Zacks Equity Research
Strength in US operations, stemming from higher patient days and revenue per patient day, is expected to have aided Acadia Healthcare's (ACHC) Q2 performance. Rising expenses are likely to have partially offset the same.
Best Value Stocks to Buy for July 25th
by Zacks Equity Research
MOV, SEM and JACK made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 25, 2023.